Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
Haematologica|April 19, 2012
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trialAndreas L Petzer, Dominic Fong, Thomas Lion, et al.
Leukemia|August 16, 2022
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trialHeiner Zimmermann, Christian Koenecke, Martin H Dreyling, et al.
Haematologica|February 11, 2010
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" studyAndreas L Petzer, Dominik Wolf, Dominic Fong, et al.
European Journal of Haematology|July 31, 2018
Recommendations for the diagnosis and treatment of patients with polycythaemia veraAntónia Hatalova, Jiri Schwarz, Mirjana Gotic, et al.
Journal of Cancer Research and Clinical Oncology|August 7, 2023
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancerViktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, et al.
Nature Medicine|July 19, 2016
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liverIgor Theurl, Ingo Hilgendorf, Manfred Nairz, et al.
EMBO Molecular Medicine|April 24, 2014
Fibrates ameliorate the course of bacterial sepsis by promoting neutrophil recruitment via CXCR2Ivan Tancevski, Manfred Nairz, Kristina Duwensee, et al.
Blood|March 5, 2021
JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionalityTata Nageswara Rao, Nils Hansen, Jan Stetka, et al.
Medicine|May 20, 2016
γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative NeoplasmJan Görtzen, Lena M Hunka, Maria Vonnahme, et al.
The Lancet. Haematology|April 10, 2018
Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trialMartin Wermke, Julia Eckoldt, Katharina S Götze, et al.
Pageof 34